Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Dong Woog | - |
dc.contributor.author | Cho, Jong Ho | - |
dc.contributor.author | Choi, Yong Soo | - |
dc.contributor.author | Kim, Jhingook | - |
dc.contributor.author | Kim, Hong Kwan | - |
dc.contributor.author | Zo, Jae Ill | - |
dc.contributor.author | Shim, Young Mog | - |
dc.date.accessioned | 2024-01-10T07:30:28Z | - |
dc.date.available | 2024-01-10T07:30:28Z | - |
dc.date.issued | 2016-07 | - |
dc.identifier.issn | 1759-7706 | - |
dc.identifier.issn | 1759-7714 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/70933 | - |
dc.description.abstract | Background: Patients with malignant pleural effusion have a limited life expectancy. An increase in pleural and oncological treatment options and more accurate prognostic evaluation may help individualize treatment strategies. The aim of this study was to identify the prognostic indicators of overall survival (OS) after video-assisted thoracic surgery (VATS) talc pleurodesis for malignant pleural effusion. Methods: We examined the medical records of all consecutive patients with malignant pleural effusion who underwent VATS talc pleurodesis from 2006 to 2008 at the Samsung Medical Center. Univariate and multivariate analyses were used to identify predictors of OS after VATS talc pleurodesis. Results: During the study period, 91 patients underwent VATS talc pleurodesis to treat malignant pleural effusion. Early (within 30 days) and late (within 90 days) postoperative mortality rates were 9.9% (9 patients), and 25.3% (23), respectively. Median survival time after VATS talc pleurodesis was 10.5 months. The postoperative respiratory complication rate was 11% (10 patients), and included pneumonia (9) and acute respiratory distress syndrome (4). Multivariate analysis revealed that preoperative chemotherapy (P = 0.012), preoperative radiotherapy (P = 0.003), and Eastern Cooperative Oncology Group (ECOG) performance score 3 or 4 (P = 0.013) were independent risk factors of OS after VATS talc pleurodesis. Conclusions: We identified previous chemotherapy or radiotherapy and poor performance status (ECOG 3 or 4) as significant predictors of OS after VATS talc pleurodesis. These prognostic factors can help surgeons select candidates for VATS pleurodesis for malignant pleural effusion. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY | - |
dc.title | Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion | - |
dc.type | Article | - |
dc.identifier.doi | 10.1111/1759-7714.12354 | - |
dc.identifier.bibliographicCitation | THORACIC CANCER, v.7, no.4, pp 393 - 398 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000383724800003 | - |
dc.identifier.scopusid | 2-s2.0-84990242323 | - |
dc.citation.endPage | 398 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 393 | - |
dc.citation.title | THORACIC CANCER | - |
dc.citation.volume | 7 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | Malignant | - |
dc.subject.keywordAuthor | pleurodesis | - |
dc.subject.keywordAuthor | pleural effusion | - |
dc.subject.keywordAuthor | talc | - |
dc.subject.keywordAuthor | video-assisted surgery | - |
dc.subject.keywordPlus | QUALITY-OF-LIFE | - |
dc.subject.keywordPlus | SURGICAL PALLIATION | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | IRRADIATION | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Respiratory System | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Respiratory System | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.